3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
1
Interventions
Docetaxel
229
Radiotherapy
206
Magnetic Resonance Spectroscopy
204
Radiosurgery
176
Gemcitabine
155
pembrolizumab
151
Nivolumab
147
enzalutamide
140
Prednisone
129
Cisplatin
123
Leuprolide
119
Androgen Antagonists
117
Abiraterone Acetate
114
Sunitinib
106
Specimen Handling
94
Surveys and Questionnaires
91
Goserelin
91
bicalutamide
90
Carboplatin
88
Ipilimumab
82
gallium 68 PSMA-11
80
Blood Specimen Collection
78
Everolimus
73
apalutamide
72
Radiation
71
Standard of Care
68
Biopsy
68
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
66
Paclitaxel
64
Cyclophosphamide
62
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Urinary Sediment Analysis
×
Genitourinary
×
Clear all
NCT00126958
2009-02-19
Cost-Effectiveness in Bladder Cancer
Erasmus Medical Center
Unknown
500 enrolled